COYA vs CUBE · rev $3.6M vs P/E 25, rev $1.07B
Coya Therapeutics, Inc. Common Stock (COYA) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported COYA revenue for 2024-12-31 was $3.6M. Net income was -$14.9M. Revenue was down 40.8% from 2023-12-31 to 2024-12-31. COYA currently screens at market cap $118.0M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
COYA currently screens at market cap $118.0M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the COYA and CUBE stock pages for the full models.
Not investment advice.